Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY: BMY )

67.68 +0.70 (+1.05%)
Official Closing Price Updated: 7:00 PM EDT, Mar 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Bristol-Myers Squibb

< Previous 1 2
...
20 21 22 23 24 25 26 27 Next >
The 3 Smartest Stocks to Buy in a Reopening Economy
Long-term investors stand to benefit significantly from these three stocks in a reopening economy. 
Via The Motley Fool
Topics Economy
Exposures Economy
Bristol Myers Unveils More Mavacamten Data To Backup Case For Heart Drug
Bristol Myers Squibb Co (NYSE: BMY) announced a new analysis of data from the Phase 3 EXPLORER-HCM study evaluating mavacamten in patients with obstructive... 
Via Benzinga
Pfizer-Bristol Myers' Eliquis Flops In Post-Heart Surgery Trial
Pfizer Inc (NYSE: PFE) and Bristol Myers Squibb Co (NYSE: BMY) partnered Eliquis (apixaban) failed to show benefit over standard of care in preventing... 
Via Benzinga
The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off
Biotech stocks had a volatile ride in the week ended May 14, with stocks moving lower for much of the week before coming back up strongly in the final session. Some of the weakness may be traced back... 
Via Talk Markets
Exposures Product Safety
The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off
Biotech stocks had a volatile ride in the week ended May 14, with stocks moving broadly lower for much of the week before coming back up strongly in the final session. Some of the... 
Via Benzinga
Exposures Product Safety
Long-Term Holds For Growth
While pondering the wildest yet still possible set of outcomes, let's take a look at some of my solid, long-term 
Via Talk Markets
4 Reasons I Do Not Fear A Market Crash
This bull market could last another year or more, or it could abruptly end any day now. As they say in Wall Street parlance, they do not ring a bell at the top or bottom of a market. 
Via Talk Markets
2 Top Healthcare Stocks for 2021 and Beyond
These two companies should be on your radar. 
Via The Motley Fool
9 Health Care Stocks Showing Unusual Options Activity In Today's Session
This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option diverges away... 
Via Benzinga
Market Briefing For Wednesday, May 5
Janet Yellen said 'interest rates may need to rise moderately', and that's a part of the backdrop, though S&P has been set-up for decline for awhile. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Cathie Wood Sheds $33.6M Alibaba Shares On Earnings Day
Cathie Wood-led Ark Investment Management on Thursday shed 162,840 shares, worth about $33.6 million, in Alibaba Group Holding (NYSE: BABA) after the company posted its first... 
Via Benzinga
2 Top Stocks to Buy and Hold for 10 Years
Our constant need for medical products will be a major growth driver for these healthcare giants. 
Via The Motley Fool
Bristol Myers Squibb's Latest Data Could Help the Pharma Leapfrog Rival Merck
LAG-3 is the new PD-1. 
Via The Motley Fool
This Data Could Accelerate Bristol Myers Squibb's Cancer Drug Opportunity
Investors will have to wait for the full data set to see how much the drug could really help cancer patients. 
Via The Motley Fool
Biopharma Stocks Stall After Earnings, Lag Over 52 Weeks
It is hard to forecast with the current choppy setting in the biopharma sector, but assuming that the COVID-19 vaccinations are on track in the U.S., financial results should improve for most large-cap... 
Via Talk Markets
Exposures COVID-19
Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates
Following a mixed month in April, the Food and Drug Administration sets out to review another slate of drugs in May. ACADIA Pharmaceuticals Inc.'s (NASDAQ: ACAD) Nuplazid... 
Via Benzinga
What Investors Need to Know About This $419,500 CAR-T Cancer Treatment
Abecma is on the market. 
Via The Motley Fool
Bristol-Myers Downgrade, Under Armour Upgrade Among Today's Top Calls
Check out today's top analyst calls from around Wall Street. Such discussions include various companies such as Comcast, Nike, and DraftKings. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For April 30, 2021
Upgrades For SPS Commerce Inc (NASDAQ:SPSC), Northland Capital Markets upgraded the previous rating of Market Perform to Outperform. In the first quarter, SPS Commerce... 
Via Benzinga
The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29) AtriCure, Inc. (NASDAQ:... 
Via Benzinga
Bristol-Myers Squibb (BMY) Q1 2021 Earnings Call Transcript
BMY earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Another Heavy News Day
For whatever it is worth, markets seem keen on the proposed measures, boosted by a nicely lower level of new unemployment insurance claims last week. 
Via Talk Markets
Why Bristol Myers Squibb Stock Fell Today
The big drugmaker reported disappointing first-quarter results. 
Via The Motley Fool
Bristol-Myers Misses Q1 Profit As Pandemic Hits Cancer Drugs Sales
Bristol-Myers Squibb Co (NYSE: BMY) joined other drugmakers in missing first-quarter earnings consensus due to a decline in medical visits and new diagnoses... 
Via Benzinga
What Went Wrong for Bristol Myers Squibb in Q1
Part of the problem was the company's strong performance a year ago. 
Via The Motley Fool
Bristol Myers Stock Dives As First-Quarter Comes Up Unexpectedly Light
Bristol Myers Squibb on Thursday reported adjusted profit of $1.74 per share on $11.07 billion in sales for its first quarter. In response, BMY stock fell. 
Via Investor's Business Daily
Bristol-Myers Squibb: Q1 Earnings Insights
Shares of Bristol-Myers Squibb (NYSE:BMY) decreased 1.5% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 1.16% year... 
Via Benzinga
A Peek Into The Markets: US Stock Futures Rise; Apple Tops Q2 Estimates
Pre-open movers U.S. stock futures traded higher in early pre-market trade after Apple Inc. (NASDAQ: AAPL) reported better-than-expected quarterly results. Investors are awaiting... 
Via Benzinga
The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:... 
Via Benzinga
8 Stocks To Watch For April 29, 2021
Some of the stocks that may grab investor focus today are: Wall Street expects Caterpillar Inc. (NYSE: CAT) to report quarterly earnings at $1.94 per share on revenue of $11.09... 
Via Benzinga
< Previous 1 2
...
20 21 22 23 24 25 26 27 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.